Literature DB >> 25512209

Urothelial carcinoma: PECULIAR, but promising.

Robert Phillips.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25512209     DOI： 10.1038/nrurol.2014.342

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17).

Authors:  Y J Choi; S H Lee; J-L Lee; J-H Ahn; K-H Lee; D You; B Hong; J H Hong; H Ahn
Journal:  Br J Cancer       Date:  2014-11-27       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.